Innovation

Inhibition of Src for MI

Caritas St. Elizabeth's Medical Center
posted on 02/13/2009

Description: During myocardial infarction the entire myocardium experiences decreased flow due in part to edema resulting in response to the onset of ischemic injury. Similarly the ischemia/reperfusion of percutaneous and surgical revascularization procedures is known to cause myocardial injury. Our studies have shown that inhibition of Src significantly reduces myocardial injury, thus enhancing recovery from myocardial infarction and revascularization procedures. This approach could be used for treatment of all ischemic chest pain including myocardial infarction, unstable angina. It also could be used prophylactically in all coronary revascularization procedures inlcluding percutaneous (angioplasty, stent, atherectomy, cutting balloon, drug eluting stent, rotational atherectomy, etc) and surgical (bypass).


Innovation Details
 

File Number: CSEMC-014 

Other Information:

Investigator(s)
Douglas Losordo

Contact
Todd Keiller, fax 508/497-0733


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Abi Barrow at Caritas St. Elizabeth's Medical Center for more information.

Request more info via email request more info
People

Case Manager:

Abi Barrow Abi Barrow

Innovations (0)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

8,771 members 16,654 innovations 159 organizations

Browse

Linda L. Restifo, M.D., Ph.D. - University of Arizona

"I want to say again how happy I am about the iBridge Network mechanism. This seems ideal for NeuronMetrics and I'm very pleased we will be part of this venture."  read more...